Background Psoriasis is a debilitating chronic inflammatory autoimmune disease affecting
approximately 7.4 million adults in the United States. Plaque psoriasis is the most common …

Objectives Our aim was to analyze the results of published randomized controlled trials
(RCTs) on vitamin D supplementation for psoriasis in order to explore its effectiveness and …

Engaging global key opinion leaders, the International Psoriasis Council (IPC) held a day-
long roundtable discussion with the primary purpose to discuss the treatment goals of …

Planners of interventional studies in psoriasis face the dilemma of selecting suitable quality‐
of‐life (QoL) measures. Systematic reviews have the potential of identifying psychometrically …

By relying on data from existing patient-reported outcome measures of quality of life, the true
impact of skin conditions on patients' lives may be underestimated. This study systematically …

Background Psoriasis is a disease of enormous socio‐economic impact. Despite approval of
numerous highly efficient and costly therapies, a minor proportion of severely affected …

Background: Many cases of psoriasis begin in adolescence. The affected adolescents face
the combined physical and psychosocial challenges of their disease-free peers with the …

Psoriasis is a chronic immune-mediated inflammatory disease that predominantly affects the
skin and joints. Its detrimental effects on the physical, psychosocial, and emotional well …

Introduction: Treatment adherence continues to be a major challenge in psoriasis. Patient
preference studies, especially discrete-choice experiments, are gaining popularity to gather …

Background Psoriasis Area and Severity Index (PASI) response rates have been the
benchmark for evaluating treatment efficacy in trials involving moderate-to-severe psoriasis …